Form 4: Thermo Fisher Scientific Director Dion J. Weisler Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Dion J. Weisler reports acquisition of phantom stock units and holdings in Thermo Fisher Scientific.
Summary
- On March 30, 2024, Dion J. Weisler, a director of Thermo Fisher Scientific Inc., reported changes in beneficial ownership.
- Weisler acquired 64.52 phantom stock units at a price of $581.21 per unit under the Issuer's Deferred Compensation Plan for Directors.
- These stock units are convertible into common stock on a 1-for-1 basis and are distributable as stock upon cessation of director service or a change of control.
- Following the reported transaction, Weisler holds 2,125.43 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation and investment in the company.
Positives
- The acquisition of phantom stock units reflects the director's continued investment in the company's future.
- The Deferred Compensation Plan for Directors aligns the interests of directors with those of shareholders.
Future Outlook
The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.
Industry Context
This filing is a routine disclosure related to director compensation and holdings, common in publicly traded companies.
Stakeholder Impact
- The filing provides transparency to shareholders regarding director compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 03/30/2024 | Date of transaction: acquisition of phantom stock units. |
| 04/02/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.